Newamsterdam Pharma Stock Analysis

NewAmsterdam Stock Analysis Notes

The company had not issued any dividends in recent years. NewAmsterdam Pharma had 1:1 split on the 23rd of November 2022. To find out more about NewAmsterdam Pharma contact FACC Facp at 31 35 206 2971 or learn more at https://www.newamsterdampharma.com.

NewAmsterdam Pharma Investment Alerts

NewAmsterdam Pharma Environmental, Social, and Governance (ESG) Scores

NewAmsterdam Profitablity

Management Efficiency

The company has return on total asset (ROA) of (0.207) % which means that it has lost $0.207 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.3994) %, meaning that it generated substantial loss on money invested by shareholders. NewAmsterdam Pharma's management efficiency ratios could be used to measure how well NewAmsterdam Pharma manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.34 in 2026. Return On Capital Employed is likely to drop to -0.28 in 2026. At this time, NewAmsterdam Pharma's Total Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to climb to about 42.3 K in 2026, whereas Other Current Assets are likely to drop slightly above 6.5 M in 2026.

Technical Drivers

As of the 4th of February, NewAmsterdam Pharma secures the Mean Deviation of 2.88, risk adjusted performance of (0.02), and Standard Deviation of 5.12. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of NewAmsterdam Pharma, as well as the relationship between them. Please verify NewAmsterdam Pharma market risk adjusted performance and treynor ratio to decide if NewAmsterdam Pharma is priced some-what accurately, providing market reflects its recent price of 20.0 per share. Given that NewAmsterdam Pharma has information ratio of (0.04), we recommend you to check NewAmsterdam Pharma's last-minute market performance to make sure the company can sustain itself at a future point.

NewAmsterdam Pharma Price Movement Analysis

NewAmsterdam Pharma Insider Trading Activities

NewAmsterdam Pharma Outstanding Bonds

NewAmsterdam Pharma Predictive Daily Indicators

NewAmsterdam Pharma Corporate Filings

NewAmsterdam Pharma Forecast Models

NewAmsterdam Pharma's time-series forecasting models are one of many NewAmsterdam Pharma's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary NewAmsterdam Pharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

NewAmsterdam Pharma Total Assets Over Time

NewAmsterdam Pharma Assets Financed by Debt

The debt-to-assets ratio shows the degree to which NewAmsterdam Pharma uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

NewAmsterdam Pharma Debt Ratio

0.1

It appears most of the NewAmsterdam Pharma's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the NewAmsterdam Pharma's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of NewAmsterdam Pharma, which in turn will lower the firm's financial flexibility.

NewAmsterdam Pharma Corporate Bonds Issued

NewAmsterdam Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how NewAmsterdam Pharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling NewAmsterdam shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as NewAmsterdam Pharma. By using and applying NewAmsterdam Stock analysis, traders can create a robust methodology for identifying NewAmsterdam entry and exit points for their positions.

When running NewAmsterdam Pharma's price analysis, check to measure NewAmsterdam Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NewAmsterdam Pharma is operating at the current time. Most of NewAmsterdam Pharma's value examination focuses on studying past and present price action to predict the probability of NewAmsterdam Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NewAmsterdam Pharma's price. Additionally, you may evaluate how the addition of NewAmsterdam Pharma to your portfolios can decrease your overall portfolio volatility.